Table of Contents

company-logo

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

Immunocore Dividend Announcement

• Immunocore does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Immunocore dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Immunocore Dividend History

Immunocore Dividend Yield

Immunocore current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Immunocore stock? Use our calculator to estimate your expected dividend yield:

Immunocore Financial Ratios

P/E ratio-32.25
PEG ratio-0.32
P/B ratio4.59
ROE-14.67%
Payout ratio0.00%
Current ratio3.78
Quick ratio3.76
Cash Ratio2.02

Immunocore Dividend FAQ

Does Immunocore stock pay dividends?
Immunocore does not currently pay dividends to its shareholders.
Has Immunocore ever paid a dividend?
No, Immunocore has no a history of paying dividends to its shareholders. Immunocore is not known for its dividend payments.
Why doesn't Immunocore pay dividends?
There are several potential reasons why Immunocore would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Immunocore ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Immunocore has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Immunocore a dividend aristocrat?
Immunocore is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Immunocore a dividend king?
Immunocore is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Immunocore a dividend stock?
No, Immunocore is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Immunocore stocks?
To buy Immunocore you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Immunocore stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.